Skip to main content
. 2023 Aug 2;11:168. doi: 10.1186/s40168-023-01595-x

Fig. 5.

Fig. 5

Relative abundance of the top 25 genera at day -7, 5, 13, 25, and 35 across the 3 intervention groups supplemented with A scGOS/lcFOS/2’-FL diet only B scGOS/lcFOS/2’-FL and B. breve NRBB01 and, C scGOS/lcFOS/2’-FL and the Bifidobacterium strain Mix without clindamycin treatment. Groups treated with clindamycin between day 7 and 14 (marked by red box) include groups supplemented with D scGOS/lcFOS/2’-FL diet only, E scGOS/lcFOS/2’-FL and B. breve NRBB01, and F scGOS/lcFOS/2’-FL and the Bifidobacterium strain mix. N = 5/group; unassigned genera have been excluded, Figure S3 details the taxonomic composition for individual animals with unassigned genera included